Industry Growth Insights published a new data on “Radiopharmaceuticals in Nuclear Medical Market”. The research report is titled “Radiopharmaceuticals in Nuclear Medical Market research by Types (Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals, Enriched Stable Isotopes), By Applications (Diagnostic Application, Therapeutic Application, Research, Pharmaceutical, Industrial), By Players/Companies Bracco Imaging, Cambridge Isotope Laboratories, Cardinal Health, Medtronic, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Lantheus Medical Imaging, Nordion, Ntp Radioisotopes, Siemens Healthcare, Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Radiopharmaceuticals in Nuclear Medical Market Research Report
By Type
Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals, Enriched Stable Isotopes
By Application
Diagnostic Application, Therapeutic Application, Research, Pharmaceutical, Industrial
By Companies
Bracco Imaging, Cambridge Isotope Laboratories, Cardinal Health, Medtronic, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Lantheus Medical Imaging, Nordion, Ntp Radioisotopes, Siemens Healthcare, Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Radiopharmaceuticals in Nuclear Medical Market Report Segments:
The global Radiopharmaceuticals in Nuclear Medical market is segmented on the basis of:
Types
Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals, Enriched Stable Isotopes
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Application, Therapeutic Application, Research, Pharmaceutical, Industrial
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bracco Imaging
- Cambridge Isotope Laboratories
- Cardinal Health
- Medtronic
- Eczacibasi-Monrol
- Fujifilm Holdings Corporation
- GE Healthcare (Subsidiary Of General Electric Company)
- IBA Group
- Lantheus Medical Imaging
- Nordion
- Ntp Radioisotopes
- Siemens Healthcare
- Taiyo Nippon Sanso Corporation
- Urenco Limited
- Rotem Industries
Highlights of The Radiopharmaceuticals in Nuclear Medical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Radiopharmaceuticals
- Therapy Radiopharmaceuticals
- Enriched Stable Isotopes
- By Application:
- Diagnostic Application
- Therapeutic Application
- Research
- Pharmaceutical
- Industrial
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radiopharmaceuticals in Nuclear Medical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radiopharmaceuticals are medications that use radiation to treat diseases. They are often used in nuclear medicine, which is a type of medical care that uses radioactive materials to diagnose and treat diseases.
Some of the key players operating in the radiopharmaceuticals in nuclear medical market are Bracco Imaging, Cambridge Isotope Laboratories, Cardinal Health, Medtronic, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Lantheus Medical Imaging, Nordion, Ntp Radioisotopes, Siemens Healthcare, Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Radiopharmaceuticals in Nuclear Medical Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Radiopharmaceuticals in Nuclear Medical Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Radiopharmaceuticals in Nuclear Medical Market - Supply Chain
4.5. Global Radiopharmaceuticals in Nuclear Medical Market Forecast
4.5.1. Radiopharmaceuticals in Nuclear Medical Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Radiopharmaceuticals in Nuclear Medical Market Size (000 Units) and Y-o-Y Growth
4.5.3. Radiopharmaceuticals in Nuclear Medical Market Absolute $ Opportunity
5. Global Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Type
5.3.1. Diagnostic Radiopharmaceuticals
5.3.2. Therapy Radiopharmaceuticals
5.3.3. Enriched Stable Isotopes
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Application
6.3.1. Diagnostic Application
6.3.2. Therapeutic Application
6.3.3. Research
6.3.4. Pharmaceutical
6.3.5. Industrial
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Radiopharmaceuticals in Nuclear Medical Demand Share Forecast, 2019-2026
9. North America Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Application
9.4.1. Diagnostic Application
9.4.2. Therapeutic Application
9.4.3. Research
9.4.4. Pharmaceutical
9.4.5. Industrial
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Type
9.7.1. Diagnostic Radiopharmaceuticals
9.7.2. Therapy Radiopharmaceuticals
9.7.3. Enriched Stable Isotopes
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Radiopharmaceuticals in Nuclear Medical Demand Share Forecast, 2019-2026
10. Latin America Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Application
10.4.1. Diagnostic Application
10.4.2. Therapeutic Application
10.4.3. Research
10.4.4. Pharmaceutical
10.4.5. Industrial
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Type
10.7.1. Diagnostic Radiopharmaceuticals
10.7.2. Therapy Radiopharmaceuticals
10.7.3. Enriched Stable Isotopes
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Radiopharmaceuticals in Nuclear Medical Demand Share Forecast, 2019-2026
11. Europe Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Application
11.4.1. Diagnostic Application
11.4.2. Therapeutic Application
11.4.3. Research
11.4.4. Pharmaceutical
11.4.5. Industrial
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Type
1.7.1. Diagnostic Radiopharmaceuticals
11.7.2. Therapy Radiopharmaceuticals
11.7.3. Enriched Stable Isotopes
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Radiopharmaceuticals in Nuclear Medical Demand Share, 2019-2026
12. Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Application
12.4.1. Diagnostic Application
12.4.2. Therapeutic Application
12.4.3. Research
12.4.4. Pharmaceutical
12.4.5. Industrial
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Type
12.7.1. Diagnostic Radiopharmaceuticals
12.7.2. Therapy Radiopharmaceuticals
12.7.3. Enriched Stable Isotopes
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Radiopharmaceuticals in Nuclear Medical Demand Share, 2019-2026
13. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Application
13.4.1. Diagnostic Application
13.4.2. Therapeutic Application
13.4.3. Research
13.4.4. Pharmaceutical
13.4.5. Industrial
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Market Size and Volume Forecast by Type
13.7.1. Diagnostic Radiopharmaceuticals
13.7.2. Therapy Radiopharmaceuticals
13.7.3. Enriched Stable Isotopes
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Radiopharmaceuticals in Nuclear Medical Market: Market Share Analysis
14.2. Radiopharmaceuticals in Nuclear Medical Distributors and Customers
14.3. Radiopharmaceuticals in Nuclear Medical Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bracco Imaging
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cambridge Isotope Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cardinal Health
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Medtronic
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eczacibasi-Monrol
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Fujifilm Holdings Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GE Healthcare (Subsidiary Of General Electric Company)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. IBA Group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lantheus Medical Imaging
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nordion
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ntp Radioisotopes
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Siemens Healthcare
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Taiyo Nippon Sanso Corporation
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Urenco Limited
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Rotem Industries
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
